EFSA position on Codex issues In EFSA19th August 20211 Min read E This content is restricted to site members. If you are an existing user, please log in. acetamiprid acetochlor afidopyropen alpha-cypermethrin azoxystrobin benzovindiflupyr beta-cypermethrin bifenthrin boscalid buprofezin carbendazim chlorantraniliprole chlorothalonil clethodim Codex cyantraniliprole cyclaniliprole cypermethrin cyprodinil dicamba dimethoate EFSA Fenazaquin flonicamid fluazifop-p-butyl fluensulfone flupyradifurone fosetyl glyphosate kresoxim-methyl mandestrobin mesotrione Metaflumizone metconazole MRL omethoate pendimethalin Penthiopyrad picoxystrobin pydiflumetofen pyflubumide Pyridate pyrifluquinazon pyriofenone pyriproxyfen S-methoprene scientific report Spirotetramat tebuconazole thiabendazole tolclofos-methyl tolfenpyrad triflumuron Valifenalate zeta-cypermethrin
26th April 2023 EFSA expert meetings May 2023 In EFSA26th April 20231 Min read 26April This content is restricted to site members. If you are an existing user, please log in.
25th April 2023 EFSA Statement targeted assessment famoxadone In EFSA25th April 20231 Min read 25April This content is restricted to site members. If you are an existing user, please log in.
24th April 2023 EFSA Statement on acibenzolar-S-methyl ED testing programme In EFSA24th April 20231 Min read 24April This content is restricted to site members. If you are an existing user, please log in.
21st April 2023 EFSA reports on magnesium hydroxide as basic substance In EFSA21st April 20232 Min read 21April This content is restricted to site members. If you are an existing user, please log in.